Gemina Laboratories Ltd.
GLAB
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -77.21% | 26.87% | 40.20% | 51.80% | 61.12% |
| Total Depreciation and Amortization | 7.61% | 6.93% | 26.45% | 43.48% | 85.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 255.73% | -72.93% | -16.64% | -41.86% | -204.89% |
| Change in Net Operating Assets | 11.73% | 17.85% | 6.65% | 79.61% | -37.05% |
| Cash from Operations | -513.11% | 35.85% | 69.72% | 61.08% | 102.49% |
| Capital Expenditure | -- | -- | -- | -- | 164.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 8.33% | -- | -- | -- | 103.56% |
| Total Debt Issued | -- | -75.00% | -- | -- | -- |
| Total Debt Repaid | -18.18% | -16.67% | -33.66% | -64.88% | -57.14% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 75.58% | 100.00% |
| Cash from Financing | 15.82% | -93.80% | 2,468.87% | -73.88% | -109.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,957.14% | -46.49% | 121.10% | -99.93% | 99.62% |